Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
Neurodegenerative diseases (ND), including Alzheimer’s (AD) and Parkinson’s Disease (PD), are becoming increasingly more common and are recognized as a social problem in modern societies. These disorders are characterized by a progressive neurodegeneration and are considered one of the main causes o...
Main Authors: | Pedro Cruz-Vicente, Luís A. Passarinha, Samuel Silvestre, Eugenia Gallardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/8/2193 |
Similar Items
-
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
by: Nidhi Puranik, et al.
Published: (2025-02-01) -
Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
by: Madeline M. Vroom, et al.
Published: (2024-08-01) -
Does gut microbiota have an impact on the origin of Alzheimer's and Parkinson's disease? – literature review
by: Izabela Oleksak, et al.
Published: (2024-02-01) -
In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy
by: Charles Gnanaraj, et al.
Published: (2022-04-01) -
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
by: Wendy Balestri, et al.
Published: (2024-01-01)